BEVERLY, Mass.--(BUSINESS WIRE)--INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced that INVO Bioscience will be attending the 9th Annual Colombia Congress of International Fertility and Reproduction on September 23rd-25th in Bogota. INVO will be presenting the INVOcell and INVO technology with their largest South American Distributor, The Daxley Group. “We will be extending our physician contacts in South America at this meeting with the support of the Daxley Group and Columbian Fertility leader Dr. Elkin Lucena” said Kathleen Karloff, INVO Bioscience CEO.
